Tyrosine-kinase inhibitor discontinuation in chronic myeloid leukaemia after deep molecular response: a meta-analysis with meta-regression.

Authors :: Rivano M
Cancanelli L
Zovi A
Addis C
Mengato D
Chiumente M
Messori A
Source :: Journal of chemotherapy (Florence, Italy) [J Chemother] 2020 Sep; Vol. 32 (5), pp. 268-271. Date of Electronic Publication: 2020 Jan 25.
Publication Year :: 2020

Subjects :: Humans
Prognosis
Remission Induction
Leukemia, Myelogenous, Chronic, BCR-ABL Positive drug therapy
Protein Kinase Inhibitors therapeutic use
Protein-Tyrosine Kinases antagonists & inhibitors
Withholding Treatment statistics & numerical data

Full Text Access

Tools